SHAREHOLDER ALERT: The Law Firm Of Levi & Korsinsky, LLP Launches An Investigation Into Avanir Pharmaceuticals, Inc. Regarding Possible Breaches Of Fiduciary Duty

Levi & Korsinsky, LLP is investigating Avanir Pharmaceuticals, Inc. (NasdaqGS:AVNR) in connection with possible claims of breaches of fiduciary duty by certain members of the board of directors.

To get more information, click here: http://zlk.9nl.com/avanir-pharmaceuticals-avnr. There is no cost or obligation to you.

If you own common stock in Avanir Pharmaceuticals, Inc. and wish to obtain additional information, please contact Eduard Korsinsky, Esq. either via email at ek@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/avanir-pharmaceuticals-avnr.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut and Washington D.C. The firm’s 26 attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.

Copyright Business Wire 2010

If you liked this article you might like

Develop Biotech 'Buy-Sell' Strategy

Develop Biotech 'Buy-Sell' Strategy

Two Small-Cap Biotechs To Consider

Two Small-Cap Biotechs To Consider

Next Year's Stock Returns: 5% or 15%?

Next Year's Stock Returns: 5% or 15%?

Updating a Small Speculative Play

Updating a Small Speculative Play

Three Large-Cap Growth Stocks

Three Large-Cap Growth Stocks